Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-25 @ 2:18 AM
NCT ID:
NCT03254134
Eligibility Criteria:
Inclusion Criteria:
* patients aged \>18 year-old with confirmed diagnosis of Non-Valvular Atrial Fibrillation (NVAF) (ICD 10 code I48)
* having a first prescription (index date) of either dabigatran or warfarin between 14 March 2011 to 30 June 2016
* having no prescription of any Oral Anticoagulants (OACs) for 12 months prior to the index date (this period is defined as the baseline period)
Exclusion Criteria:
* patients having less than 12 months of enrolment prior to the index date
* being dialysis or kidney transplant recipients in baseline period
* having either atrial flutter, valvular atrial fibrillation (AF)
* mechanical valve placement, rheumatic AF
* and/or mitral valve prolapse/regurge/stenosis in baseline period
* having record of deep vein thrombosis or pulmonary embolism \< 6 months before AF diagnosis in baseline period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03254134
Study Brief:
Protocol Section:
NCT03254134